Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania

by Nyundo,Salama, Adamson,Ester, Rowland,Jessica, Palermo,Pedro M., Matiko,Mirende, Bettinger,George E., Wambura,Philemon, Morrill,John C., Watts,Douglas
Published 2019

Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile

by Monath, Thomas P., Kortekaas, Jeroen, Watts, Douglas M., Christofferson, Rebecca C., Desiree LaBeaud, Angelle, Gowen, Brian, Peters, Clarence J., Smith, Darci R., Swanepoel, Robert, Morrill, John C., Ksiazek, Thomas G., Pittman, Phillip R., Bird, Brian H., Bettinger, George